Aurinia Pharmaceuticals


Aurinia’s Kidney Disease Treatment Wins FDA Approval; Street Sees 78% Upside

Aurinia Pharmaceuticals announced that the US Food and Drug Administration (FDA) has approved its Lupkynis (voclosporin) treatment for use in adult patients with …

Aurinia Tanks 10% As Dry Eye Trial Fails To Reach Primary Endpoint

Shares in Aurinia Pharmaceuticals (AUPH) tanked 10% after-hours after the biopharma announced disappointing topline data from the Phase 2/3 Audrey clinical study evaluating …

Aurinia Pharma Surges 9% On Priority Review For Lupus Kidney Treatment

Shares in Aurinia Pharma (AUPH) surged 9% in Tuesday’s extended trading after the U.S.

Aurinia Submits FDA New Drug Admission For Novel Voclosporin Kidney Treatment

Shares in Aurinia Pharmaceuticals, Inc (AUPH) advanced in pre-market trading as the biotech company announced the submission of the New Drug Application (NDA) …

3 “Strong Buy” Small-Cap Stocks with Towering Growth Prospects

Finding a stock which will deliver enormous returns is the Street’s holy grail. Upon first glance, this task may seem rather simple.

Cantor Comments on Aurinia Pharmaceuticals (AUPH) Following 1Q18 Update

Cantor analyst Elemer Piros is out with a short research note on shares of Aurinia Pharmaceuticals (NASDAQ:AUPH), following the company’s first-quarter financial results and update on …

H.C. Wainwright Believes Aurinia Pharmaceuticals Inc (AUPH) Wins Big with Results of End-of-Phase 2 Meeting with FDA

Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) just scored what H.C.

Analysts Weigh in on Volatile Biotech Stocks: Alnylam Pharmaceuticals, Inc. (ALNY) and Aurinia Pharmaceuticals (AUPH)

Analysts offer insights into a volatile biotech-verse amid Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) shares dipping on news of a program termination and Aurinia Pharmaceuticals (NASDAQ:AUPH) soaring on …

Company Update (NASDAQ:AUPH): Here’s Why Aurinia Pharmaceuticals Inc Jumped 28% Today

Investors in Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) should be smiling from ear to ear today after the company announced positive 24-week data in 10 patients from …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts